Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.30 |
| ▸ | LMNA | P02545 | 2/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4576548 | 0.79 | — | — | |
| SCHEMBL25442 | 0.71 | — | — | |
| SCHEMBL30477387 | 0.68 | — | — | |
| Hydrogen Peroxide SCHEMBL8626398 | 0.68 | ALDH1A1 (0.50) | ALDH1A1TSHRHSD17B10LMNATDP1 | |
| Methane SCHEMBL27609142 | 0.68 | — | — | |
| Acetone SCHEMBL226043 | 0.68 | LMNA (0.55) | ALDH1A1TSHRHSD17B10LMNATDP1 | |
| SCHEMBL29931207 | 0.68 | — | — | |
| SCHEMBL2991355 | 0.68 | — | — | |
| SCHEMBL29877272 | 0.68 | — | — | |
| SCHEMBL1706581 | 0.68 | ALDH1A1 (0.50) | ALDH1A1TSHRHSD17B10LMNATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080311099-A1 | Pyridoxal-5-Phosphate and Related Compounds in Combination With Therapeutic Cardiovascular Compounds for Treating Angina | MEDICURE INTERNATIONAL INC. | 2008-12-18 | — | — | US | disclosed |
| US-7442689-B2 | Cardioprotective phosphonates and malonates | MEDICURE INTERNATIONAL INC. (BB) | 2008-10-28 | — | — | US | disclosed |
| US-20070167411-A1 | Compositions for treating angina | MEDICURE INTERNATIONAL INC. (BB) | 2007-07-19 | — | — | US | disclosed |
| US-20070032456-A1 | Modulation of cell death | MEDICURE INC. (CA) | 2007-02-08 | — | — | US | disclosed |
| US-7105673-B2 | Cardioprotective phosphonates and malonates | MEDICURE INTERNATIONAL INC. (BB) | 2006-09-12 | — | — | US | disclosed |
| EP-1610783-A2 | MODULATION OF CELL DEATH | Medicure Inc. (CA) | 2006-01-04 | — | — | EP | disclosed |
| EP-1608379-A1 | COMPOSITIONS FOR TREATING ANGINA | Medicure Inc. (CA) | 2005-12-28 | — | — | EP | disclosed |
| EP-1531157-A1 | Cardioprotective phosphonates | Medicure International Inc. (BB) | 2005-05-18 | — | — | EP | disclosed |
| EP-1268498-B1 | CARDIOPROTECTIVE PHOSPHONATES | MEDICURE INT INC (BB) | 2005-04-13 | — | — | EP | disclosed |
| US-6867215-B2 | Cardioprotective phosphonates and malonates | MEDICURE INTERNATIONAL INC. (BB) | 2005-03-15 | — | — | US | disclosed |
| US-20030120074-A1 | Cardioprotective phosphonates and malonates | MEDICURE INTERNATIONAL INC. (BB) | 2003-06-26 | — | — | US | disclosed |
| US-20030114677-A1 | Cardioprotective phosphonates and malonates | MEDICURE INTERNATIONAL INC. (BB) | 2003-06-19 | — | — | US | disclosed |
| US-20030114424-A1 | Treatment of cerebrovascular disease | MEDICURE INTERNATIONAL INC. (BB) | 2003-06-19 | — | — | US | disclosed |
| US-20030114678-A1 | Cardioprotective phosphonates and malonates | MEDICURE INTERNATIONAL INC. (BB) | 2003-06-19 | — | — | US | disclosed |
| EP-1278526-A2 | TREATMENT OF CEREBROVASCULAR DISEASE | Medicure International Inc. (BB) | 2003-01-29 | — | — | EP | disclosed |
| EP-1268498-A1 | CARDIOPROTECTIVE PHOSPHONATES AND MALONATES | Medicure International Inc. (BB) | 2003-01-02 | — | — | EP | disclosed |
| US-20020010158-A1 | Cardioprotective phosphonates and malonates | MEDICURE INTERNATIONAL INC. (CA) | 2002-01-24 | — | — | US | disclosed |
| US-20010056081-A1 | Treatment of cerebrovascular disease | MEDICURE INTERNATIONAL INC. (CA) | 2001-12-27 | — | — | US | disclosed |
| WO-2001072309-A2 | TREATMENT OF CEREBROVASCULAR DISEASE | MEDICURE INTERNATIONAL INC. (US) | 2001-10-04 | — | — | WO | disclosed |
| WO-2001064692-A1 | CARDIOPROTECTIVE PHOSPHONATES AND MALONATES | MEDICURE INTERNATIONAL INC. (BB) | 2001-09-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030114677-A1 | Cardioprotective phosphonates and malonates | PDXK, PHOSPHO1, PNPO | ALDH1A1 2080/4885TSHR 3443/4885HSD17B10 1185/4885 |
| US-20070167411-A1 | Compositions for treating angina | PNPO, PYGM, PLPBP | ALDH1A1 1367/4885TSHR 3843/4885HSD17B10 1898/4885 |
| US-20080311099-A1 | Pyridoxal-5-Phosphate and Related Compounds in Combination With Therapeutic Cardiovascular Compounds for Treating Angina | ALOX5, PNPO, KCNMB1 | ALDH1A1 1179/4885TSHR 3439/4885HSD17B10 1128/4885 |
| US-20020010158-A1 | Cardioprotective phosphonates and malonates | PDXK, PHOSPHO1, PNPO | ALDH1A1 2080/4885TSHR 3443/4885HSD17B10 1185/4885 |
| US-20030120074-A1 | Cardioprotective phosphonates and malonates | PDXK, PHOSPHO1, PNPO | ALDH1A1 2080/4885TSHR 3443/4885HSD17B10 1185/4885 |
| US-20010056081-A1 | Treatment of cerebrovascular disease | PNPO, PLPBP, VNN1 | ALDH1A1 1352/4885TSHR 3254/4885HSD17B10 2057/4885 |
| US-20070032456-A1 | Modulation of cell death | CASP6, CASP3, CASP5 | ALDH1A1 3492/4885TSHR 3908/4885HSD17B10 3585/4885 |
| US-20030114678-A1 | Cardioprotective phosphonates and malonates | PDXK, PHOSPHO1, PNPO | ALDH1A1 2080/4885TSHR 3443/4885HSD17B10 1185/4885 |
| US-20030114424-A1 | Treatment of cerebrovascular disease | PNPO, PLPBP, VNN1 | ALDH1A1 1352/4885TSHR 3254/4885HSD17B10 2057/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.